19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Both neutralization and antibody-dependent cellular cytotoxicity (ADCC) may be required for effective protection against HIV-1 infection. While there is extensive information on the targets of early neutralizing antibody (nAb) responses, much less is known about the targets of ADCC responses, which are more difficult to characterize. In four individuals recruited during acute HIV-infection, ADCC responses were detected 3–7 weeks prior to nAb responses. To determine the relative influence of ADCC and nAb responses on virus evolution, we performed an in-depth investigation of one individual (CAP63) who showed the highest nAb and ADCC responses. Both nAbs and ADCC antibodies targeted the V4 region of the Env, although there were some differences in epitope recognition. We identified accelerated viral evolution in this region concurrent with emergence of nAb activity, but not ADCC activity. Deep sequencing demonstrated that most nAb escape mutations were strongly selected for, however one nAb escape mutation that rendered the virus highly susceptible to autologous ADCC responses, was suppressed despite not affecting viral fitness. This escape mutation also rendered the virus more sensitive to autologous responses, as well as monoclonal antibodies targeting CD4-induced epitopes, compared to the wildtype virus. In conclusion, ADCC responses and nAbs in donor CAP63 recognized overlapping but unique epitopes in the V4 region, and while ADCC activity was present prior to nAbs, it did not drive viral evolution during this time. However, ADCC responses may select against nAb escape pathways that expose other common ADCC epitopes thereby restricting viral replication and expansion.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.

          HIV-1-specific immunoglobulin G (IgG) subclass antibodies bind to distinct cellular Fc receptors. Antibodies of the same epitope specificity but of a different subclass therefore can have different antibody effector functions. The study of IgG subclass profiles between different vaccine regimens used in clinical trials with divergent efficacy outcomes can provide information on the quality of the vaccine-induced B cell response. We show that HIV-1-specific IgG3 distinguished two HIV-1 vaccine efficacy studies (RV144 and VAX003 clinical trials) and correlated with decreased risk of HIV-1 infection in a blinded follow-up case-control study with the RV144 vaccine. HIV-1-specific IgG3 responses were not long-lived, which was consistent with the waning efficacy of the RV144 vaccine. These data suggest that specific vaccine-induced HIV-1 IgG3 should be tested in future studies of immune correlates in HIV-1 vaccine efficacy trials.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID.

            Viruses can create complex genetic populations within a host, and deep sequencing technologies allow extensive sampling of these populations. Limitations of these technologies, however, potentially bias this sampling, particularly when a PCR step precedes the sequencing protocol. Typically, an unknown number of templates are used in initiating the PCR amplification, and this can lead to unrecognized sequence resampling creating apparent homogeneity; also, PCR-mediated recombination can disrupt linkage, and differential amplification can skew allele frequency. Finally, misincorporation of nucleotides during PCR and errors during the sequencing protocol can inflate diversity. We have solved these problems by including a random sequence tag in the initial primer such that each template receives a unique Primer ID. After sequencing, repeated identification of a Primer ID reveals sequence resampling. These resampled sequences are then used to create an accurate consensus sequence for each template, correcting for recombination, allelic skewing, and misincorporation/sequencing errors. The resulting population of consensus sequences directly represents the initial sampled templates. We applied this approach to the HIV-1 protease (pro) gene to view the distribution of sequence variation of a complex viral population within a host. We identified major and minor polymorphisms at coding and noncoding positions. In addition, we observed dynamic genetic changes within the population during intermittent drug exposure, including the emergence of multiple resistant alleles. These results provide an unprecedented view of a complex viral population in the absence of PCR resampling.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env-V2

              Summary The RV144 trial demonstrated 31% vaccine efficacy (VE) at preventing HIV-1 infection 1 . Antibodies against the HIV-1 envelope variable loops 1 and 2 (V1/V2) domain correlated inversely with infection risk 2 . We hypothesized that vaccine-induced immune responses against V1/V2 would selectively impact, or sieve, HIV-1 breakthrough viruses. 936 HIV-1 genome sequences from 44 vaccine and 66 placebo recipients were examined. We show that vaccine-induced immune responses were associated with two signatures in V1/V2 at amino-acid positions 169 and 181. VE against viruses matching the vaccine at position 169 was 48% (CI: 18 to 66%; p=0.0036), whereas VE against viruses mismatching the vaccine at position 181 was 78% (CI: 35% to 93%; p=0.0028). Residue 169 is in a cationic glycosylated region recognized by broadly neutralizing and RV144-derived antibodies. The predicted distance between the two signatures sites (21±7 Å), and their match/mismatch dichotomy, suggest that multiple factors may be involved in the protection observed in RV144. Genetic signatures of RV144 vaccination in V2 complement the finding of an association between high V1/V2 binding antibodies and reduced risk of HIV-1 acquisition and provide evidence that vaccine-induced V2 responses plausibly played a role in the partial protection conferred by the RV144 regimen.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                11 December 2019
                2019
                : 10
                : 2875
                Affiliations
                [1] 1Division of Medical Virology, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town , Cape Town, South Africa
                [2] 2Duke University Medical Center , Durham, NC, United States
                [3] 3HIV Virology Section, Centre for HIV and STIs, National Institute for Communicable Diseases , Johannesburg, South Africa
                [4] 4National Health Laboratory Service , Johannesburg, South Africa
                [5] 5MRC Antibody Immunity Research Unit, University of Witwaterstrand , Johannesburg, South Africa
                [6] 6Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu Natal , Durban, South Africa
                [7] 7Department of Medicine, University of Alabama at Birmingham , Birmingham, AL, United States
                [8] 8Research Service, Birmingham Veterans Affairs Medical Center , Birmingham, AL, United States
                [9] 9Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu Natal , Durban, South Africa
                [10] 10Department of Epidemiology, Columbia University , New York, NY, United States
                Author notes

                Edited by: Lucia Lopalco, San Raffaele Hospital (IRCCS), Italy

                Reviewed by: P. J. Klasse, Weill Cornell Medicine, United States; Martyn Andrew French, University of Western Australia, Australia

                *Correspondence: Carolyn Williamson carolyn.williamson@ 123456uct.ac.za

                This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology

                †These authors have contributed equally to this work

                Article
                10.3389/fimmu.2019.02875
                6919271
                31921139
                f68d5594-435e-4f76-bbcb-889e3b0c7c2e
                Copyright © 2019 Mielke, Bandawe, Pollara, Abrahams, Nyanhete, Moore, Thebus, Yates, Kappes, Ochsenbauer, Garrett, Abdool Karim, Tomaras, Montefiori, Morris, Ferrari and Williamson.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 02 October 2019
                : 22 November 2019
                Page count
                Figures: 7, Tables: 0, Equations: 1, References: 52, Pages: 14, Words: 9736
                Categories
                Immunology
                Original Research

                Immunology
                adcc,cd4-induced,neutralizing antibody,selection,escape
                Immunology
                adcc, cd4-induced, neutralizing antibody, selection, escape

                Comments

                Comment on this article